Dr Sarah Consonni

Postdoctoral Fellow

After obtaining her PhD in Molecular Cancer Research, Sarah gained some experience in a pharmaceutical company and a medical consulting firm.

Her current work in the Garnett group aims to investigate the interplay between tumor-immune cells and to provide insights into the mechanisms of drug resistance and new therapeutic targets.